77 / 464
SATURDAY 6 MAY 2017
INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG
77
Programme and Exhibition Guide |
SCIENTIFIC PROGRAMME
09:35 > Evaluation of time, attendance of medical staff,and resources during
stereotactic radiotherapy/radiosurgery: QUIRO-DEGRO trial
Speaker: J. Hörner-Rieber (Germany)
SP-0027
SYMPOSIUMWITH PROFFERED PAPERS
Novel approaches in heart / lung matters
08:45 - 10:00 | LEHAR 4
Recent data suggesting that cardiac toxicity is not an exclusively late occurring
complication has revived that interest in it mechanistic basis and approaches for
prevention and treatment. Therefore, pathogenic mechanisms, associated therapeutic
targets and experimental work testing potential therapeutics to modulate the
induction of cardiac damage by (chemo-) radiotherapy, will be discussed.
Chair: P. Van Luijk (The Netherlands)
Co-chair: A. De Vries (Austria)
08:45 > State of the art in heart effects
M.C. Vozenin (Switzerland)
SP-0028
09:12 > Pharmacological modulation of cardiac radiation injury
M. Boerma (USA)
SP-0029
09:39 >
In vitro
study of FLASH vs. conventional dose-rate irradiation: Cell
viability and DNA damage repair
A. Beddok (France), C. Fouillade, E. Quelennec, V. Favaudon
OC-0030
09:49 > Global changes in the glycosylation of irradiated endothelial cells with
functional consequences
C. Jaillet, W. Morelle, M.C. Slomianny, V. Paget, G. Tarlet, V. Buard,
S. Selbonne, F. Caffin, E. Rannou, P. Martinez, A. François, F. Foulquier,
F. Allain, F. Milliat, O. Guipaud (France)
OC-0031
SYMPOSIUM
Expanding brachytherapy indications
08:45 - 10:00 | STOLZ 1-2
Integrating modern imaging modalities or tools of interventional radiology as
part of the management of cancer patients might provide new opportunities
for brachytherapy in a variety of indications. In fact, the next step of treatment
optimisation in brachytherapy might rely on multidisciplinary therapeutic strategies,
based either on a more accurate definition of target volumes, or providing a
minimally invasive access to treat target lesions in deep anatomic sites or close
to critical organs. This session will give an overview on how could brachytherapy
indications be expanded or refined by a comprehensive integration of high-tech